NCT05716828 is a NA clinical trial of Balint group activities in Burnout, sponsored by Peking University People's Hospital.

Who is sponsoring NCT05716828?

NCT05716828 is sponsored by Peking University People's Hospital.

What drugs are being tested in NCT05716828?

Interventions in NCT05716828: Balint group activities.

What condition does NCT05716828 study?

NCT05716828 studies Burnout, Self Efficacy.

Is NCT05716828 still recruiting?

NCT05716828 is currently completed. Last updated 8 February 2023.

Last reviewed 2023-02-08 · How we verify

NCT05716828

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Balint Group on Burnout and Self-efficacy of Nurse Leaders in China: A Randomised Controlled Trial

Completed NA Last updated 8 February 2023

What this trial tests

NA trial testing Balint group activities in Burnout in 40 participants. Completed in 1 January 2022.

Timeline

1 July 2020

Primary endpoint
1 January 2022

1 January 2022

Quick facts

Lead sponsor	Peking University People's Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	single
Primary purpose	treatment
Enrollment	40
Start date	1 July 2020
Primary completion	1 January 2022
Estimated completion	1 January 2022
Sites	1 location across China

Drugs / interventions tested

Balint group activities

Conditions studied

Burnout — all drugs for Burnout →
Self Efficacy — all drugs for Self Efficacy →

Sponsor

Peking University People's Hospital

Who can join

Eligibility, any sex, with Burnout or Self Efficacy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: Burnout is common among nurses and is related to negative outcomes of medical care. This study aimed to explore the effectiveness of Balint group activities in burnout reduction among nurse leaders in a Chinese hospital. Methods: This was a randomised controlled trial with a pre- and post-test. A total of 80 nurse leaders were randomly assigned to either a Balint group (n=40) or a non-Balint group (n=40). Participants in the Balint group completed Balint training for a period of three months. Participants in both groups completed the Maslach Burnout Inventory-Human Services Survey (MBI) and the General Self-Efficacy Scale (GSES) at the beginning and end of the study（three months later ）. Balint group members also completed the Group Climate Questionnaire-Short Format the end of the study（three months later ）.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

The effects of cognitive behavioral therapy on health-related quality of life, anxiety, depression, illness perception, and in atrial fibrillation patients: a six-month longitudinal study.
Minjie Z, Zhijuan X, Xinxin S, Xinzhu B, et al · · 2023 · cited 12× · PMID 38062475 · DOI 10.1186/s40359-023-01457-z
Positive effect of Balint group on burnout and self-efficacy of head nurses in China: a randomized controlled trial.
Shan Q, Leonhart R, Zhijuan X, Minjie Z, et al · · 2023 · cited 2× · PMID 38260785 · DOI 10.3389/fpsyt.2023.1265976

Verify or expand the search:

Other recruiting trials for Burnout

Currently open trials in the same condition.

NCT07298018 — A Pilot Study of RISE for Nurse Managers Retreat · NA · recruiting
NCT07255313 — Strengthening Health Literacy in Healthcare Workers Through Mind Body Medicine and Nutrition · NA · recruiting
NCT07031245 — Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout · NA · recruiting
NCT07171697 — Mindful-Med: the Evaluation of the Mindfulness-based Stress-coping and Burnout Prevention Programme for Medical Interns. · NA · active not recruiting
NCT06939426 — Music Therapy and Humanization in ED Healthcare Professionals · NA · recruiting

Other Peking University People's Hospital trials

Trials by the same sponsor.

NCT07535645 — Baricitinib for Post-HSCT Persistent Thrombocytopenia · Phase 1, PHASE2 · not yet recruiting
NCT07516002 — Immunoglobulin Efficacy and Immune Profiling in Antibody Immunodeficiency · not yet recruiting
NCT07294339 — A Randomized Controlled Trial of Acupuncture for the Management of Hot Flashes in Patients With Hormone Receptor-Positiv · NA · not yet recruiting
NCT07500441 — Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML · recruiting
NCT07487883 — Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05716828 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking University People's Hospital
Last refreshed: 8 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05716828.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing